|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Physiology, The University of Melbourne, Melbourne, Victoria, Australia
2 Physiology, The University of Melbourne, Victoria, Victoria, Australia
3 Physiology, University of Melbourne Faculty of Medicine, Parkville, Victoria, Australia
* To whom correspondence should be addressed. E-mail: lmd{at}unimelb.edu.au.
Important sex differences in cardiovascular disease outcomes exist, including conditions of hypertrophic cardiomyopathy and cardiac ischemia. Studies of sex differences in the extent to which load-independent (primary) hypertrophy modulates the response to ischemia/reperfusion (I/R) damage has not been characterized. We have previously described a model of primary genetic cardiac hypertrophy, the Hypertrophic Heart Rat (HHR). In this study the sex differences in HHR cardiac function and responses to I/R (compared to control Normal Heart Rat, NHR) were investigated ex vivo. Ventricular weight index was markedly increased in HHR female (7.82 ± 0.49 vs 4.80 ± 0.10 mg/g, P<0.05) and male (5.76 ± 0.22 vs 4.62 ± 0.07 mg/g, p<0.05) hearts. Female hearts of both strains exhibited a reduced basal contractility compared with strain-matched males (dP/dtmax mmHg/s; NHR: 4036 ± 171 vs 4258 ± 152; HHR: 3974 ± 160 vs 4540 ± 259; p<0.05). HHR hearts were more susceptible to I/R (I= 25min, R= 30min) injury than NHR hearts (decreased functional recovery, increased lactate dehydrogenase efflux). Female NHR hearts exhibited a significantly greater recovery (dP/dtmax) post I/R relative to male NHR (95.0 ± 12.2 vs 60.5 ± 9.4%), a resistance to post-ischemic dysfunction not evident in female HHR (29.0 ± 5.6 vs 25.9 ± 6.3 %). Ventricular fibrillation was suppressed and expression levels of Akt and ERK1/2 were selectively elevated in female NHR hearts. Thus, the occurrence of load-independent primary cardiac hypertrophy undermines the intrinsic resistance of female hearts to ischemia-reperfusion insult, with the observed abrogation of endogenous cardioprotective signaling pathways consistent with a potential mechanistic role in this loss of protection.
This article has been cited by other articles:
![]() |
E. R. Porrello, A. D'Amore, C. L. Curl, A. M. Allen, S. B. Harrap, W. G. Thomas, and L. M.D. Delbridge Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor-Mediated Cardiomyocyte Autophagy Hypertension, June 1, 2009; 53(6): 1032 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Huggins, C. L. Curl, R. Patel, P. L. McLennan, M. L. Theiss, T. Pedrazzini, S. Pepe, and L. M. D. Delbridge Dietary fish oil is antihypertrophic but does not enhance postischemic myocardial function in female mice Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H957 - H966. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Porrello, J. R. Bell, J. D. Schertzer, C. L. Curl, J. R. McMullen, K. M. Mellor, R. H. Ritchie, G. S. Lynch, S. B. Harrap, W. G. Thomas, et al. Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R672 - R680. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |